Non-Opioid Pain Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 10
SKU : PH1153
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Non-Opioid Pain Treatment Market ?
Non-Opioid Pain Treatment Market is expected to grow at a CAGR of 8% during the forecast period 2024-2031.
Who are the key players in Non-Opioid Pain Treatment Market ?
Major players are Aphria Inc, Aurora, Bedrocan, Canopy Growth Corp, Cara Therapeutics, Centrexion Therapeutics, Cronos Group, GW Pharmaceuticals, Medical Marijuana Inc, Medropharm Gmbh, Panag Pharma Inc, Tilray, US Worldmeds LLC and Vanway.
Related Reports
pharmaceuticalsChronic Pain Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 23
Starting from
$4350
pharmaceuticalsHemophilia A Treatment Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 September 28
Starting from
$4350
medical-devicesSpina Bifida Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 February 10
Starting from
$4350